Skip to Content

The Fascinating World of Using Molecular Imaging in Primary and Metastatic Breast Cancer

Based on new guidelines for the use of FDG PET/CT in both primary and metastatic breast cancer, Malene Hildebrandt, Clinical Professor and Head of Research at the Department of Nuclear Medicine at Odense University Hospital, presents some clinical issues that need to be addressed.

Malene Grubbe Hildebrandt

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top